Results from Trial to Reduce IDDM in the Genetically at Risk -TRIGR

A long-asked research question has finally been answered: is it possible to prevent Type 1 diabetes by altering the kind of formula that infants are exposed to in the first months of life? After 14 years, following 2159 children in 15 countries, researchers involved in the Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study conclusively showed that altering the type of protein in infant formula does not affect the risk of developing Type 1 diabetes in children who had a family member with Type 1 diabetes